Ragosa Mark Insider Trading Activity
10
Total trades
$6.7M
Total volume
Mar 9, 2026
Last activity
Kiniksa Pharmaceuticals International, plc
Ragosa Mark has been net-selling over the last 12 months with 0 purchases and 9 sales across 1 company.
KNSA is the most-traded position with 9 trades. The largest single transaction was a sale of KNSA for $1.8M on Dec 8, 2025.
Performance Scorecard
Forward stock performance after each transaction by Ragosa Mark. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -3.7% | 10% | 10 |
| 90 days | — | -17.8% | 0% | 8 |
| 120 days | — | -21.8% | 0% | 6 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKNSA · Kiniksa Pharmaceuticals International, plc
🔒 Subscribe to see trade entries
Pro members see exactly when Ragosa Mark bought and sold KNSA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | KNSA | Sell | 17,981 | $45.58 | $820K | CFO |
| Mar 9, 2026 | KNSA | Sell | 18,741 | $46.24 | $867K | CFO |
| Feb 9, 2026 | KNSA | Sell | 9,114 | $42.85 | $391K | CFO |
| Feb 9, 2026 | KNSA | Sell | 8,731 | $43.72 | $382K | CFO |
| Jan 8, 2026 | KNSA | Sell | 12,000 | $41.89 | $503K | CFO |
| Dec 8, 2025 | KNSA | Sell | 42,841 | $41.49 | $1.8M | CFO |
| Nov 12, 2025 | KNSA | Sell | 19,900 | $40.94 | $815K | CFO |
| Oct 28, 2025 | KNSA | Sell | 100 | $41.00 | $4K | CFO |
| Aug 4, 2025 | KNSA | Sell | 18,889 | $32.89 | $621K | CFO |
| Jun 3, 2025 | KNSA | Sell | 18,299 | $28.80 | $527K | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | 10 | $6.7M |
Other insiders at Kiniksa Pharmaceuticals International, plc
7 other tracked filers at KNSA.